VRTX · NASDAQ · Biotechnology

Vertex Pharmaceuticals

Develops cystic fibrosis medicines, gene-edited cell therapy, and non-opioid pain treatment.

$540.78
After-hours close−0.92 (−0.17%)
At close$541.69(−1.07%)
DateEstimateReportedSurprise
Nov 2026$4.80
Aug 2026$4.74$4.73−0.2%
May 2026$4.24$4.47+5.4%
Feb 2026$5.11$5.03−1.6%
Nov 2025$4.57$4.80+5.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Oct 2022
Aug 2022
May 2022
Jan 2022
Nov 2021
Jul 2021
Apr 2021
Feb 2021
Oct 2020
Jul 2020
Apr 2020
Jan 2020
Oct 2019
Jul 2019
Apr 2019
Feb 2019
Oct 2018
Jul 2018
Apr 2018
Jan 2018
Oct 2017
Jul 2017
Apr 2017
Jan 2017
Oct 2016
Jul 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 2, 2026$4.80$3.41B
Aug 3, 2026$4.74$4.73−0.2%$3.23B$3.33B+3.2%
May 4, 2026$4.24$4.47+5.4%$2.99B$2.99B−0.2%
Feb 12, 2026$5.11$5.03−1.6%$3.18B$3.19B+0.2%
Nov 3, 2025$4.57$4.80+5.0%$3.06B$3.08B+0.6%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 4, 2025
May 5, 2025
Feb 10, 2025
Nov 4, 2024
Aug 1, 2024
May 6, 2024
Feb 5, 2024
Nov 6, 2023
Aug 1, 2023
May 1, 2023
Feb 7, 2023
Oct 27, 2022
Aug 4, 2022
May 5, 2022
Jan 26, 2022
Nov 2, 2021
Jul 29, 2021
Apr 29, 2021
Feb 1, 2021
Oct 29, 2020
Jul 30, 2020
Apr 29, 2020
Jan 30, 2020
Oct 30, 2019
Jul 31, 2019
Apr 30, 2019
Feb 5, 2019
Oct 24, 2018
Jul 25, 2018
Apr 26, 2018
Jan 31, 2018
Oct 25, 2017
Jul 26, 2017
Apr 27, 2017
Jan 25, 2017
Oct 25, 2016
Jul 27, 2016
Apr 27, 2016
Jan 27, 2016
Oct 28, 2015
Jul 29, 2015